Zinc finger proteins are key regulators of normal morphogenesisi and can also act as either oncogenes or tumor suppressors. The investigators laboratory has been focused on studying the role of these proteins in the regulation of pancreatic gene expression, cell growth, and the modulation of neoplastic transformation. Pancreatic cancer currently ranks fifth as a cause of death by cancer in the USA and has one fo the poorest prognoses among the human neoplasias. Although the etiology and pathophysiology of pancreatic ductal cancer is poorly understood, increasing evidence indicates that alterations in transcription factors (e.g. DPC4/Smad4) are often associated with this disease. Furthermore, transcription factors such as p53 are beginning to be tested as genetic therapeutic tools to treat this disease. The proposal is focused on the biochemical and functional characterization of KS1, a novel zinc finger transcription factor isolated from the pancreas that represses transcription and suppresses neoplastic transformation. Both of these functional properties of KS1 are interrelated since the deletion of a distinct transcriptional repressor domain, R2 abolishes the ability of this protein to suppress neoplastic transformation. Currently, however, the mechanisms that KS1 uses to perform these functions are poorly understood. Moreover, the role of KS1 in the regulation of pancreatic epithelial cell growth is also undefined. In this proposal, the investigator will test the central hypothesis that KS1 is a sequence-specific transcriptional repressor protein that inhibits cell growth and neoplastic transformation by regulating apoptosis and/or cell proliferation. The investigator will use state-of-the-art biochemical and molecular techniques combined with well established assays and cell models for studying neoplastic transformation and pancreatic epithelial cell growth. The proposed aims are to: 1) determine the role of KS1 in the regulation of cell proliferation and apoptosis, 2) determine the DNA binding activity of KS1, and 3) characterize the mechanisms underlying the function of the R2 domain of KS1 as a transcriptional repressor and suppressor of transformation. The investigator expects that successful completion of this proposal will provide novel information on molecular mechanisms used by zinc finger proteins to regulate cell growth and neoplastic transformation. This knowledge will serve as the foundation for future studies aimed at using these proteins as therapeutic tools for controlling abnormal cell growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK056620-01A1
Application #
6197832
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Serrano, Jose
Project Start
2000-09-15
Project End
2004-07-31
Budget Start
2000-09-15
Budget End
2001-07-31
Support Year
1
Fiscal Year
2000
Total Cost
$182,019
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Lomberk, Gwen; Wallrath, Lori; Urrutia, Raul (2006) The Heterochromatin Protein 1 family. Genome Biol 7:228
Natesampillai, Sekar; Fernandez-Zapico, Martin E; Urrutia, Raul et al. (2006) A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function. J Biol Chem 281:3040-7
Buttar, Navtej S; Fernandez-Zapico, Martin E; Urrutia, Raul (2006) Key role of Kruppel-like factor proteins in pancreatic cancer and other gastrointestinal neoplasias. Curr Opin Gastroenterol 22:505-11
Billadeau, Daniel D; Chatterjee, Subrha; Bramati, Patricia et al. (2006) Characterization of the CXCR4 signaling in pancreatic cancer cells. Int J Gastrointest Cancer 37:110-9
Lomberk, Gwen; Bensi, Debora; Fernandez-Zapico, Martin E et al. (2006) Evidence for the existence of an HP1-mediated subcode within the histone code. Nat Cell Biol 8:407-15
Lomberk, Gwen; Urrutia, Raul (2005) The family feud: turning off Sp1 by Sp1-like KLF proteins. Biochem J 392:1-11
Randriamahefa, Alexandrine; Fernandez-Zapico, Martin E; Mladek, Ann C et al. (2005) The first initiative targeted to increase the training of African-American scientists in pancreatic cancer research: the Mayo Clinic College of Medicine-Oakwood College alliance. Pancreas 30:288-91
Fernandez-Zapico, Martin E; Gonzalez-Paz, Natalia C; Weiss, Ellen et al. (2005) Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell 7:39-49
Neve, Bernadette; Fernandez-Zapico, Martin E; Ashkenazi-Katalan, Vered et al. (2005) Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc Natl Acad Sci U S A 102:4807-12
Fernandez-Zapico, Martin E; Bramati, Patricia S; Zakaria, Shaheen et al. (2003) Fundamentals of transcription factors and their impact on pancreatic development and cancer. Pancreatology 3:276-83

Showing the most recent 10 out of 17 publications